Incyte (INCY): are the analysts right?

Incyte · Health Care · ref. ETF XLV · 51 calls · price $118.05
What the company does: Incyte Corporation est une société de biopharmaceutique découvrant et commercialisant des thérapies, notamment JAKAFI et ICLUSIG.
📈 1-year price
$118.05+74.4% over range
Jul 8, 25low $67.38 · high $118.05Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
36% recommend buying · 14 analysts
⚠️ The stock trades above the median target: it has beaten expectations. The “Hold” reflects conviction on the company, but the remaining quantified upside is low/negative.

🎯 Analyst price target on INCY

High target · 1 analyst$140+18.6%
Median target · 13 analysts$110-6.8%
Low target · 1 analyst$90-23.8%
Current price$118.05

🗳️ The analyst consensus

Analyst breakdown · 14 (6 months)
Strong Buy0%
Buy36%
Hold64%
Sell0%
Strong Sell0%

✅ Historical analyst reliability on INCY

📊 What $1,000 invested in Incyte would be worth

In short — $1,000 invested in Incyte 10 years ago would be worth $1,045 today, i.e. +0%/yr on average. Best year: 2025 (+43%), worst: 2018 (-33%). Price performance, excluding dividends.

If I'd invested $1,000 in Incyte

InvestmentWorth todayGain
1 years ago$1,641+64%
3 years ago$1,411+41%
5 years ago$1,303+30%
10 years ago$1,045+5%
since inception (1993)$50,382+4938%

Return by year (Incyte)

YearReturn$1,000 invested at year start
2026 (YTD)+15%$1,148 (+15%)
2025+43%$1,641 (+64%)
2024+10%$1,805 (+81%)
2023-22%$1,411 (+41%)
2022+9%$1,544 (+54%)
2021-16%$1,303 (+30%)
20200%$1,298 (+30%)
2019+37%$1,783 (+78%)
2018-33%$1,197 (+20%)
2017-6%$1,131 (+13%)
2016-8%$1,045 (+5%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on INCY

RBC Capital
Jul 7, 26
■ Sector Perform neutral · not a buy · 🎯$99
Today : $118.05 — gap to target -16%
🎯 on INCY : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Jul 7, 27
▲ Buy · 🎯$140
Price at call : $114.66 — upside +22%
Today : $118.05 — upside +19%
🎯 on INCY : no call matured yet · 📊 on Health : 51% · +0.6% (51 calls)
in progress (365j)
matures : Jun 29, 27
UBS
Jun 26, 26
■ Neutral neutral · not a buy · 🎯$113
Price at call : $114.66 — gap to target -1%
Today : $118.05 — gap to target -4%
🎯 on INCY : no call matured yet · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Jun 26, 27
▲ Buy · 🎯$140
Price at call : $108.46 — upside +29%
Today : $118.05 — upside +19%
🎯 on INCY : no call matured yet · 📊 on Health : 51% · +0.6% (51 calls)
in progress (365j)
matures : Jun 24, 27
■ Hold neutral · not a buy · 🎯$105
Price at call : $104.4 — gap to target +1%
Today : $118.05 — gap to target -11%
🎯 on INCY : no call matured yet · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : Jun 22, 27
BMO Capital
Jun 22, 26
■ Market Perform neutral · not a buy · 🎯$94
Price at call : $103.66 — gap to target -9%
Today : $118.05 — gap to target -20%
🎯 on INCY : no call matured yet · 📊 on Health : 60.9% · +9.2% (235 calls)
in progress (365j)
matures : Jun 22, 27
▲ Buy · 🎯$140
Price at call : $105.39 — upside +33%
Today : $118.05 — upside +19%
🎯 on INCY : no call matured yet · 📊 on Health : 51% · +0.6% (51 calls)
in progress (365j)
matures : Jun 9, 27
Bernstein
May 22, 26
■ Market Perform neutral · not a buy · 🎯$99
Price at call : $97.1 — gap to target +2%
Today : $118.05 — gap to target -16%
🎯 on INCY : no call matured yet · 📊 on Health : 55.6% · +5.7% (63 calls)
in progress (365j)
matures : May 22, 27
▲ Buy · 🎯$135
Price at call : $97.41 — upside +39%
Today : $118.05 — upside +14%
🎯 on INCY : no call matured yet · 📊 on Health : 51% · +0.6% (51 calls)
in progress (365j)
matures : May 21, 27
▲ Buy · 🎯$135
Price at call : $97.14 — upside +39%
Today : $118.05 — upside +14%
🎯 on INCY : no call matured yet · 📊 on Health : 51% · +0.6% (51 calls)
in progress (365j)
matures : May 4, 27
Oppenheimer
Apr 29, 26
■ Perform neutral · not a buy · 🎯$90
Price at call : $95.27 — gap to target -6%
Today : $118.05 — gap to target -24%
🎯 on INCY : no call matured yet · 📊 on Health : 43.5% · -0.4% (216 calls)
in progress (365j)
matures : Apr 29, 27
Stifel
Apr 29, 26
▲ Buy · 🎯$123
Price at call : $99.1 — upside +24%
Today : $118.05 — upside +4%
🎯 on INCY : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : Apr 29, 27
▲ Buy · 🎯$135
Price at call : $97.1 — upside +39%
Today : $118.05 — upside +14%
🎯 on INCY : no call matured yet · 📊 on Health : 51% · +0.6% (51 calls)
in progress (365j)
matures : Apr 15, 27
▲ Buy · 🎯$135
Price at call : $90.33 — upside +49%
Today : $118.05 — upside +14%
🎯 on INCY : no call matured yet · 📊 on Health : 51% · +0.6% (51 calls)
in progress (365j)
matures : Mar 30, 27
UBS
Mar 25, 26
■ Neutral neutral · not a buy · 🎯$94
Price at call : $92.26 — gap to target +2%
Today : $118.05 — gap to target -20%
🎯 on INCY : no call matured yet · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Mar 25, 27
▲ Buy · 🎯$135
Price at call : $92.23 — upside +46%
Today : $118.05 — upside +14%
🎯 on INCY : no call matured yet · 📊 on Health : 51% · +0.6% (51 calls)
in progress (365j)
matures : Mar 25, 27
Jefferies
Mar 16, 26
■ Hold neutral · not a buy · 🎯$94
Price at call : $93 — gap to target +1%
Today : $118.05 — gap to target -20%
🎯 on INCY : no call matured yet · 📊 on Health : 50.5% · +4.5% (376 calls)
in progress (365j)
matures : Mar 16, 27
▲ Buy · 🎯$135
Price at call : $97.1 — upside +39%
Today : $118.05 — upside +14%
🎯 on INCY : no call matured yet · 📊 on Health : 51% · +0.6% (51 calls)
in progress (365j)
matures : Mar 9, 27
■ In-Line neutral · not a buy · 🎯$110
Price at call : $97.33 — gap to target +13%
Today : $118.05 — gap to target -7%
🎯 on INCY : no call matured yet · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Mar 5, 27
Barclays
Feb 18, 26
▲ Overweight · 🎯$117
Price at call : $101.73 — upside +15%
Today : $118.05 — upside -1%
🎯 on INCY : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Feb 18, 27
RBC Capital
Feb 11, 26
■ Sector Perform neutral · not a buy · 🎯$92
Price at call : $100.75 — gap to target -9%
Today : $118.05 — gap to target -22%
🎯 on INCY : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Feb 11, 27
Stifel
Feb 11, 26
▲ Buy · 🎯$120
Price at call : $100.75 — upside +19%
Today : $118.05 — upside +2%
🎯 on INCY : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : Feb 11, 27
Wells Fargo
Feb 11, 26
■ Equal-Weight neutral · not a buy · 🎯$101
Price at call : $100.75 — gap to target +0%
Today : $118.05 — gap to target -14%
🎯 on INCY : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Feb 11, 27
▲ Buy · 🎯$135
Price at call : $98.84 — upside +37%
Today : $118.05 — upside +14%
🎯 on INCY : no call matured yet · 📊 on Health : 51% · +0.6% (51 calls)
in progress (365j)
matures : Feb 11, 27
▲ Overweight · 🎯$110
Price at call : $109.03 — upside +1%
Today : $118.05 — upside -7%
🎯 on INCY : no call matured yet · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Feb 6, 27
▲ Buy · 🎯$135
Price at call : $102.76 — upside +31%
Today : $118.05 — upside +14%
🎯 on INCY : no call matured yet · 📊 on Health : 51% · +0.6% (51 calls)
in progress (365j)
matures : Feb 5, 27
Barclays
Feb 4, 26
▲ Overweight · 🎯$116
Price at call : $102.6 — upside +13%
Today : $118.05 — upside -2%
🎯 on INCY : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Feb 4, 27
Wells Fargo
Jan 20, 26
■ Equal-Weight neutral · not a buy · 🎯$107
Price at call : $102.62 — gap to target +4%
Today : $118.05 — gap to target -9%
🎯 on INCY : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Jan 20, 27
TD Cowen
Jan 13, 26
▲ Buy · 🎯$128
Price at call : $105.95 — upside +21%
Today : $118.05 — upside +8%
🎯 on INCY : no call matured yet · 📊 on Health : 48.4% · +0.8% (95 calls)
in progress (365j)
matures : Jan 13, 27
■ Equal-Weight neutral · not a buy · 🎯$94
Price at call : $110.57 — gap to target -15%
Today : $118.05 — gap to target -20%
🎯 on INCY : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Jan 6, 27
■ Equal-Weight neutral · not a buy · 🎯$92
Price at call : $95.16 — gap to target -3%
Today : $118.05 — gap to target -22%
🎯 on INCY : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Dec 8, 26
Wells Fargo
Dec 8, 25
▲ Overweight · 🎯$116
Price at call : $95.16 — upside +22%
Today : $118.05 — upside -2%
🎯 on INCY : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Dec 8, 26
Mizuho
Dec 8, 25
▲ Outperform · 🎯$121
Price at call : $96.7 — upside +25%
Today : $118.05 — upside +2%
🎯 on INCY : no call matured yet · 📊 on Health : 53.8% · +4.4% (208 calls)
in progress (365j)
matures : Dec 8, 26
Barclays
Nov 24, 25
▲ Overweight · 🎯$115
Price at call : $106.24 — upside +8%
Today : $118.05 — upside -3%
🎯 on INCY : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Nov 24, 26
▲ Overweight · 🎯$102
Price at call : $105.7 — upside -4%
Today : $118.05 — upside -14%
🎯 on INCY : no call matured yet · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Nov 4, 26
Guggenheim
Nov 3, 25
▲ Buy · 🎯$125
Price at call : $102.92 — upside +21%
Today : $118.05 — upside +6%
🎯 on INCY : no call matured yet · 📊 on Health : 52.8% · +3.9% (89 calls)
in progress (365j)
matures : Nov 3, 26
RBC Capital
Oct 29, 25
■ Sector Perform neutral · not a buy · 🎯$84
Price at call : $92.59 — gap to target -9%
Today : $118.05 — gap to target -29%
🎯 on INCY : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Oct 29, 26
■ Hold neutral · not a buy · 🎯$93
Price at call : $92.59 — gap to target +0%
Today : $118.05 — gap to target -21%
🎯 on INCY : no call matured yet · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : Oct 29, 26
Wells Fargo
Oct 29, 25
▲ Overweight · 🎯$97
Price at call : $92.59 — upside +5%
Today : $118.05 — upside -18%
🎯 on INCY : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Oct 29, 26
Barclays
Oct 29, 25
▲ Overweight · 🎯$101
Price at call : $90.18 — upside +12%
Today : $118.05 — upside -14%
🎯 on INCY : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Oct 29, 26
JP Morgan
Oct 9, 25
■ Neutral neutral · not a buy · 🎯$89
Price at call : $84.75 — gap to target +5%
Today : $118.05 — gap to target -25%
🎯 on INCY : no call matured yet · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Oct 9, 26
RBC Capital
Sep 24, 25
■ Sector Perform neutral · not a buy · 🎯$81
Price at call : $81.66 — gap to target -1%
Today : $118.05 — gap to target -31%
🎯 on INCY : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Sep 24, 26
Stifel
Sep 22, 25
▲ Buy · 🎯$115
Price at call : $84.54 — upside +36%
Today : $118.05 — upside -3%
🎯 on INCY : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : Sep 22, 26
Guggenheim
Sep 19, 25
■ Neutral neutral · not a buy
🎯 on INCY : no call matured yet · 📊 on Health : 52.8% · +3.9% (89 calls)
in progress (365j)
matures : Sep 19, 26
▲ Buy · 🎯$104
Price at call : $86.64 — upside +20%
Today : $118.05 — upside -12%
🎯 on INCY : no call matured yet · 📊 on Health : 48.6% · +2.3% (352 calls)
in progress (365j)
matures : Sep 4, 26
JP Morgan
Aug 22, 25
■ Neutral neutral · not a buy · 🎯$73
Price at call : $84.76 — gap to target -14%
Today : $118.05 — gap to target -38%
🎯 on INCY : no call matured yet · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Aug 22, 26
Wells Fargo
Aug 6, 25
▲ Overweight · 🎯$89
Price at call : $77.65 — upside +15%
Today : $118.05 — upside -25%
🎯 on INCY : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Aug 6, 26
Barclays
Aug 1, 25
▲ Overweight · 🎯$90
Price at call : $75.59 — upside +19%
Today : $118.05 — upside -24%
🎯 on INCY : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Aug 1, 26
BMO Capital
Jul 30, 25
▼ Underperform · 🎯$60
Price at call : $74.89 — upside -20%
Today : $118.05 — upside -49%
🎯 on INCY : no call matured yet · 📊 on Health : 60.9% · +9.2% (235 calls)
in progress (365j)
matures : Jul 30, 26
Citigroup
Jul 30, 25
▲ Buy · 🎯$103
Price at call : $74.89 — upside +38%
Today : $118.05 — upside -13%
🎯 on INCY : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Jul 30, 26
William Blair
Mar 18, 25
■ Market Perform neutral · not a buy
🎯 on INCY : no call matured yet · 📊 on Health : 65.4% · +5.6% (26 calls)
in progress (365j)
matures : Mar 18, 26
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)